Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03592472
Title A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Xynomic Pharmaceuticals, Inc.
Indications

renal cell carcinoma

Therapies

Pazopanib

Abexinostat + Pazopanib

Age Groups: adult | senior
Covered Countries USA | ITA | ESP


No variant requirements are available.